The aim of the study was to assess the effectiveness of progesterone (
P) administered by nasal spray (NS) in inducing secretory changes with
in estrogen and non-estrogen primed postmenopausal endometrium. Ten he
althy post-menopausal women before vaginal hysterectomy for prolapse w
ere randomly treated by either oral estrogens for 3-4 weeks combined f
or the last 5-7 days with nasally administered P at the daily dose of
34 mg, or by only P for 6 days. Endometrial samples were taken before
P administration and 8 h after the last dose. In the group not treated
with estrogens, P did not induce significant secretory changes in any
case except one which showed a proliferative endometrial pattern at t
he first evaluation. In the group treated with estrogens, in all the c
ases after P administration clear secretory changes (abundant vacuoles
, endoluminal secretion) occurred. It is possible to conclude that P a
dministered by NS exerts an end-organ effect within the endometrium of
postmenopausal women pretreated with estrogens.